Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.5180
+0.0526 (11.30%)
Nov 3, 2025, 3:12 PM EST - Market open
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $25.64 million as of November 3, 2025. Its market cap has increased by 313.55% in one year.
Market Cap
25.64M
Enterprise Value
16.16M
1-Year Change
313.55%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $25.64M, a decrease of -63.73%. That is a compound annual growth rate of -10.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 14.10M | 176.47% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
| Jun 2, 2016 | 70.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |